Developers and expert users benchmark three leading open-source thermal conductivity calculation packages

Mechanical Engineering Professor Alan McGaughey of Carnegie Mellon University recently coordinated the Phonon Olympics, ...

Arcturus outlines 12-week cystic fibrosis study launch in 2026 amid cost controls and delayed KOSTAIVE BLA

Discover key Q3 2025 earnings insights for Arcturus Therapeutics: pipeline progress, regulatory updates, and financial outlook.

ProFrac outlines $100M cost savings initiative and targets $200M capital raise amid volatile Q3

Discover ProFrac's Q3 2025 earnings highlights—cost-saving strategies, dedicated fleet focus, and future outlook amid sector volatility.
Le Lézard

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...